Hubei Hongyuan Pharmaceutical Technology (301246.SZ) supervisors Duan Xiaoliu and Lei Gaoliang have completed their share reduction period and collectively reduced their holdings by 1.1 million shares.

Announcement from Hubei Hongyuan Pharmaceutical Technology (301246.SZ): The term of the reduction plan for the supervisors Duan Xiaoliu and Lei Gaoliang has expired, with a total reduction of 1.1 million shares in the company.